Latest News - Danaher
Top Corporates Hub
Danaher
A Look At Danaher (DHR) Valuation After Strong Q1 Earnings Beat And Raised Guidance
23.05.2026 04:25
Danaher (DHR) drew fresh attention after strong first quarter results, with adjusted earnings per share ahead of expectations and full year guidance raised. This combination supported renewed interest in the stock. See our latest analysis for Danaher. Despite the positive Q1 surprise and raised guidance, Danaher’s share price return is still down 25.35% year to date and the 1 year total shareholder return is down 6.15%. Recent momentum therefore remains fragile. If earnings driven moves in...
Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board
22.05.2026 12:00
MELVILLE, N.Y., May 22, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board following 44 years as a Director of Henry Schein and was named Chairman Emeritus in recognition of his extraordinary contr
Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead?
20.05.2026 15:18
DHR's Biotechnology segment posts 7% core revenue growth as bioprocessing demand stayed strong and equipment orders jumped despite headwinds.
Pall to Address a Key Decarbonization Challenge with Additively Manufactured Filtration
20.05.2026 12:30
Pall Corporation, a Danaher company and advanced filtration leader, has been awarded $1 million CAD from the Government of Alberta through Emissions Reduction Alberta (ERA) to accelerate development of an additively manufactured flue-gas filtration solution designed to overcome pre-treatment bottlenecks and improve the reliability of carbon capture under real-world conditions. Addressing flue-gas pre-treatment challenges is critical to scaling carbon capture, utilization and storage (CCUS), a ke
Why The Narrative Around Danaher (DHR) Is Shifting With Bioprocess Recovery And Masimo Deal
20.05.2026 07:10
Danaher’s fair value estimate has been trimmed slightly from US$250.14 per share to US$247.83 per share, a small move that still matters if you are tracking entry points and valuation discipline. That shift sits against a backdrop of mixed analyst commentary, where some see improving bioprocess conditions and portfolio moves as supportive, while others focus on timing risks and the impact of recent target cuts. As you read on, you will see how these changing views fit together and what to...
Danaher Masimo Deal Shifts Growth Outlook And Investor Focus
17.05.2026 15:12
Danaher plans to complete its acquisition of Masimo (NasdaqGS:MASI) in the second half of the year. The deal is expected to affect Danaher's overall growth profile, with Masimo's bioprocessing exposure viewed as an important factor. The transaction represents a significant step for both companies, with implications for market positioning and operations once it is closed. Masimo is best known for its medical technology and patient monitoring products, and the company also has relevance in...
Danaher Valuation Reset Highlights Recurring Revenues And Lean Operating Framework
16.05.2026 02:15
Danaher (NYSE:DHR) is trading near its lowest valuation in five years, with the share price at $161.91. Market sentiment has reset sharply as industry headwinds weigh on the stock. The company continues to rely on recurring revenues, high customer loyalty and the Danaher Business Systems to support its operations. For investors watching NYSE:DHR, the reset in sentiment is striking. The stock is down 18.3% over the past month and 29.7% year to date, leaving it near a five year valuation low...
Jim Cramer Discusses the Performance of Danaher and Its Peers
14.05.2026 15:40
Danaher Corporation (NYSE:DHR) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer called it a “one-time excellent company,” as he said: For instance, Danaher, another one-time excellent company, has seen the stock just get pulverized after not-so-great quarters, or I […]
Aldevron co and Minaris renew lentiviral plasmid agreement to accelerate gene-modified cell therapy development
11.05.2026 08:54
Danaher Corp: Aldevron: co and Minaris renew lentiviral plasmid agreement to accelerate gene-modified cell therapy development...
Is Danaher (DHR) Pricing Look Interesting After Recent Life Sciences Portfolio Focus News
10.05.2026 08:09
If you are wondering whether Danaher's current share price reflects its underlying worth, the recent performance gives plenty to think about. The stock closed at US$175.66, with returns of a 1.8% decline over 7 days, 8.0% decline over 30 days, 23.8% decline year to date, 9.2% decline over 1 year, 12.7% decline over 3 years, and 19.7% decline over 5 years. Recent news around Danaher includes ongoing attention on its portfolio positioning and market role in life sciences tools, which can shape...
Danaher to Present at Bank of America Securities Healthcare Conference
06.05.2026 16:17
WASHINGTON, May 6, 2026 /PRNewswire/ -- Danaher Corporation announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care...
Investors Can Find Comfort In Danaher's (NYSE:DHR) Earnings Quality
03.05.2026 13:33
Investors were disappointed with the weak earnings posted by Danaher Corporation ( NYSE:DHR ). However, our analysis...
Danaher Euro Debt Raise Reshapes Masimo Deal And Valuation Story
30.04.2026 00:16
Danaher (NYSE:DHR) has announced a multi billion euro senior notes offering to fund its planned acquisition of Masimo Corporation. The euro denominated debt issuance is intended to cover the purchase of Masimo and may also support other corporate priorities. The move signals a major capital allocation decision and a planned expansion of Danaher's medical technology footprint. For investors watching NYSE:DHR, this financing decision comes as the share price stands at $178.8 and longer term...
3 Profitable Stocks We’re Skeptical Of
27.04.2026 14:20
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Danaher Corporation (DHR) Reports Q1 Adjusted EPS Beat
25.04.2026 15:58
Danaher Corporation (NYSE:DHR) is one of the 10 Best Slow Growth Stocks to Buy According to Analysts. On April 21, 2026, Danaher Corporation (NYSE:DHR) reported Q1 adjusted EPS of $2.06, above the $1.94 consensus, with revenue of $6B in line with expectations. Rainer Blair said the company “executed well in the first quarter,” citing nearly […]
Danaher Corporation Prices ?500,000,000 Principal Amount of Floating Rate Senior Notes Due 2028, ?750,000,000 Principal Amount of 3.250% Senior Notes Due 2030, ?750,000,000 Principal Amount of 3.625% Senior Notes Due 2034, ?1,000,000,000 Principal Am...
23.04.2026 01:20
Danaher Corporation announced that it has priced an offering of the following euro-denominated senior notes : ?500,000,000 principal amount of floating rate senior notes due 2028 at an offering price...
DHR Q1 Deep Dive: Bioprocessing Momentum and Acquisition Strategy Drive Mixed Start to 2026
22.04.2026 13:57
Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to $5.95 billion. Its non-GAAP profit of $2.06 per share was 6.4% above analysts’ consensus estimates.
Wells Fargo Maintains Equal-Weight on Danaher, Lowers Price Target to $212
22.04.2026 10:55
Wells Fargo analyst Brandon Couillard maintains Danaher (NYSE:DHR) with a Equal-Weight and lowers the price target from $240 to $212.
Guggenheim Maintains Buy on Danaher, Lowers Price Target to $235
22.04.2026 10:01
Guggenheim analyst Subbu Nambi maintains Danaher (NYSE:DHR) with a Buy and lowers the price target from $275 to $235.
Danaher Corp (DHR) Q1 2026 Earnings Call Highlights: Strong EPS Growth and Strategic ...
22.04.2026 07:01
Danaher Corp (DHR) reports robust earnings growth and strategic moves, despite challenges in diagnostics and North American markets.